4 Topic Commentaries

No-Fee CE: Myopia Beyond 2025

• 

  Michael F. Chiang, M.D.

  Ophthalmology

  •

  National Eye Institute, National Institutes of Health

  The overall mixed results on low-dose atropine show us we need more research. Would a different dose be more effective in a US population? Would combining atropine with other strategies have a synergistic effect? Could we develop other approaches to treatment or prevention based on a better understanding of what causes myopia progression?

  Source
• 

  Susan Vitale, Ph.D.

  Epidemiology

  •

  National Eye Institute, National Institutes of Health

  With the increasing prevalence of high myopia, we’ll likely see a corresponding increase in these serious complications,

  Source
• 

  David A. Berntsen, O.D., Ph.D.

  Optometry

  •

  University of Houston College of Optometry

  We believe, based on multiple animal studies, that focusing peripheral light in front of the retina is a potent stop signal for eye growth,

  Source
• 

  Donald O. Mutti, O.D., Ph.D.

  Optometry

  •

  The Ohio State University College of Optometry

  The frozen ciliary muscle no longer stretches the lens to keep pace with the growing eye, and that makes the eye myopic,

  Source